The Mary M. Wohlford Laboratory for Male Contraceptive Research, Center for Biomedical Research, Population Council, 1230 York Avenue, New York, NY 10065, USA.
Biochem J. 2011 May 1;435(3):553-62. doi: 10.1042/BJ20102121.
Spermiogenesis in the mammalian testis is the most critical post-meiotic developmental event occurring during spermatogenesis in which haploid spermatids undergo extensive cellular, molecular and morphological changes to form spermatozoa. Spermatozoa are then released from the seminiferous epithelium at spermiation. At the same time, the BTB (blood-testis barrier) undergoes restructuring to facilitate the transit of preleptotene spermatocytes from the basal to the apical compartment. Thus meiotic divisions take place behind the BTB in the apical compartment to form spermatids. These germ cells enter spermiogenesis to transform into elongating spermatids and then into spermatozoa to replace those that were released in the previous cycle. However, the mole-cular regulators that control spermiogenesis, in particular the dynamic changes that occur at the Sertoli cell-spermatid interface and at the BTB, are not entirely known. This is largely due to the lack of suitable animal models which can be used to study these events. During the course of our investigation to develop adjudin [1-(2,4-dichlorobenzyl)-1H-indazole-3-carbohydrazide] as a potential male contraceptive, this drug was shown to 'accelerate' spermiation by inducing the release of premature spermatids from the epithelium. Using this model, we have identified several molecules that are crucial in regulating the actin filament network and the unique adhesion protein complex at the Sertoli cell-spermatid interface known as the apical ES (ectoplasmic specialization). In the present review, we critically evaluate these and other findings in the literature as they relate to the restricted temporal and spatial expression of two actin regulatory proteins, namely Eps8 (epidermal growth factor receptor pathway substrate 8) and Arp3 (actin-related protein 3), which regulate these events.
哺乳动物睾丸中的精子发生是最关键的减数后发育事件,在此过程中,单倍体精母细胞经历广泛的细胞、分子和形态变化,形成精子。然后,精子在精子发生过程中从生精上皮中释放出来。与此同时,BTB(血睾屏障)经历重构,以促进preleptotene 精母细胞从基底到顶部分室的转运。因此,减数分裂发生在 BTB 后面的顶部分室中,以形成精母细胞。这些生殖细胞进入精子发生过程,转化为伸长的精母细胞,然后转化为精子,以取代在上一个周期中释放的精子。然而,控制精子发生的分子调节剂,特别是在支持细胞-精子界面和 BTB 处发生的动态变化,并不完全清楚。这在很大程度上是由于缺乏合适的动物模型来研究这些事件。在我们研究将 adjudin [1-(2,4-二氯苄基)-1H-吲唑-3-甲酰肼]开发为潜在的男性避孕药的过程中,发现这种药物通过诱导上皮细胞中过早的精母细胞释放来“加速”精子发生。使用这种模型,我们已经确定了几种在调节肌动蛋白丝网络和支持细胞-精子界面上特有的粘附蛋白复合物(称为顶 ES [胞外特化])中起关键作用的分子。在本综述中,我们批判性地评估了这些和文献中的其他发现,因为它们与两种肌动蛋白调节蛋白 Eps8(表皮生长因子受体途径底物 8)和 Arp3(肌动蛋白相关蛋白 3)的时空表达受限有关,这两种蛋白调节这些事件。